论文部分内容阅读
目的分析胺碘酮治疗冠心病室性心律失常的临床疗效。方法 120例冠心病室性心律失常患者,随机分为研究组和对比组,各60例。研究组使用胺碘酮治疗,对比组使用普罗帕酮治疗,分析两组的治疗效果。结果治疗后,研究组的治疗总有效率为96.7%,对比组为75.0%,研究组的治疗总有效率明显高于对比组,差异具有统计学意义(P<0.05)。结论胺碘酮治疗冠心病室性心律失常的临床效果显著优于普罗帕酮,并且具有安全性高、稳定性强的优点,值得在临床治疗上推广使用。
Objective To analyze the clinical effect of amiodarone on ventricular arrhythmia in patients with coronary heart disease. Methods 120 patients with coronary heart disease and ventricular arrhythmia were randomly divided into study group and control group, with 60 cases in each group. The study group treated with amiodarone, the control group treated with propafenone, the treatment effect of the two groups were analyzed. Results After treatment, the total effective rate was 96.7% in the study group and 75.0% in the control group. The total effective rate of the study group was significantly higher than that of the control group (P <0.05). Conclusion The clinical effect of amiodarone on ventricular arrhythmia in patients with coronary heart disease is significantly better than that of propafenone, and it has the advantages of high safety and stability. It is worth to promote the use of amiodarone in clinical treatment.